Hi,  welcome to EN-CPhI.cn  Sign In Join Free For Buyer

Search Inquiry Cart (0)
Anhui Biochem United Pharmaceutical Co.,Ltd.
Anhui Biochem United Pharmaceutical Co.,Ltd.
You are here: Home >> Marketing Website>> Company Profile
  • Our Company
  • Year Established: 2002

  • Total Annual Sales(USD): Choose not to disclose

  • Total Number of Staff: more than 500

  • Main Competitive Advantages:

  • Other Competitive Advantages:

  • Patents and Copyrights:

  • Our Business
  • Business Type: Manufacturer

  • Annual Sales(USD): 10,000,000 to 14,999,999

  • Main Sales Markets: Central/South America,Asia,Middle East,Africa

  • Major Product Categories: Active Pharmaceutical Ingredients , Intermediates , Excipients and Drug Formulation , Fine Chemicals

  • All Products:

  • Product Export Percentage: 100

  • Product Domestic Sale Percentage:

  • Main Clients' Names:

  • Other Information
  • Contract Manufacturing

  • Payment Terms: L/C DP TT

Company Profile
Anhui Biochem United Pharmaceutical Co., Ltd.(ABUP) is a leading Hi-Tech enterprise that specializes in research, production and marketing of anti-HIV and anti-HBV chiral drugs in China. It was formed in 2007 by Anhui Biochem Pharmaceutical that was established in 2003, and QVT Fund. ABUP is located in Taihe Country, Fuyang City, Auhui Province. It has more than four hundred staff members with a total asset of over RMB 510 million, covering an area of 50.74 acres. ABUP masters international core technology of chiral drugs and has one of biggest production and most complete variety of anti-HBV and anti-HIV/AIDS API manufacturing base in China, which starts the precedent of domestic anti-HBV and anti-HIV products and ends the history of a long term of dependence on import antiviral. ABUP has two owned subsidiaries: Anhui Biochem Bio-Pharmaceutical Co., Ltd. and Anhui Biochem Medical Sales Co., Ltd. It has formed a complete industry chain from API R&D, synthesis to formulation produ
Milestones
2002.12 Anhui Biochem Pharm Co., Ltd is established 2007.03 Lamivudine API granted by US FDA (DMF No.20468) 2007.08 Anhui Biochem Pharmaceutical Co., Ltd signs with QVT FUND LP (UK) to establish Anhui Biochem United Pharmaceutical Co., Ltd 2007.09 Anhui Biochem Pharmaceutical Co., Ltd invests 160 million yuan to establish API manufacturing base at Anhui Taihe Industrial Park 2008.04 Wholly acquire and establish subsidiary Anhui Biochem Bio-Pharmaceutical Co., Ltd, and turns the company into a complete industry chain which integrates the intermediate, API and preparation manufacturing and marketing. 2008.05 Lamivudine API is approved by Health Canada (DMF No. 2008-036) 2008.12 Anhui Biochem United Pharmaceutical has passed the high-tech enterprise certification 2009.01 The wholly owned subsidiary Anhui Biochem Medical Sales Co., Ltd is established. 2009.03 Anhui Biochem signs Memorandum of Understanding with the Clinton Foundation and has accepted on-site audit for many times
Last Updated: May 7, 2018 Add as my favorite supplier Abuse Report Product Alert
Follow Us
CPhI Online Trade Platform: Worldwide|English|中国站
Customer Service:  86-400 610 1188 (9: 00-18: 00, Mon-Fri)
About Us| Contact Us| Terms of Services| Privacy Policy| Intellectual Property Statement| Links | Site Map
Copyright 2006-20 Shanghai UBM Sinoexpo International Exhibition Co Ltd (All Rights Reserved). ICP 05034851-53
web对话
live chat
客服对话